Supplemental Fibrinogen Restores Thrombus Formation in Cardiopulmonary Bypass-induced Platelet Dysfunction Ex vivo

Overview

Journal Br J Anaesth

Publisher Elsevier

Specialty Anesthesiology

Date 2023 Apr 22

PMID 37087333

Authors

Michael Schoerghuber

Thomas Barnthaler

Florian Pruller

Polina Mantaj

Gerhard Cvirn

Wolfgang Toller

Christoph Klivinyi

Elisabeth Mahla

Akos Heinemann

Affiliations

Soon will be listed here.

Abstract

Background: Major cardiac surgery related blood loss is associated with increased postoperative morbidity and mortality. Platelet dysfunction is believed to contribute to post-cardiopulmonary bypass (CPB)-induced microvascular bleeding. We hypothesised that moderately hypothermic CPB induces platelet dysfunction and that supplemental fibrinogen can restore in vitro thrombus formation.

Methods: Blood from 18 patients, undergoing first-time elective isolated aortic valve surgery was drawn before CPB, 30 min after initiation of CPB, and after CPB and protamine administration, respectively. Platelet aggregation was quantified by optical aggregometry, platelet activation by flow-cytometric detection of platelet surface expression of P-selectin, annexin V, and activated glycoprotein IIb/IIIa, thrombus formation under flow and effect of supplemental fibrinogen (4 mg ml) on in vitro thrombogenesis.

Results: Post-CPB adenosine-diphosphate and TRAP-6-induced aggregation decreased by 40% and 10% of pre-CPB levels, respectively (P<0.0001). Although CPB did not change glycoprotein IIb/IIIa receptor expression, it increased the percentage of unstimulated P-selectin (1.2% vs 7%, P<0.01) positive cells and annexin V mean fluorescence intensity (15.5 vs 17.2, P<0.05), but decreased percentage of stimulated P-selectin (52% vs 26%, P<0.01) positive cells and annexin V mean fluorescence intensity (508 vs 325, P<0.05). Thrombus area decreased from 6820 before CPB to 5230 after CPB (P<0.05, arbitrary units [a.u.]). Supplemental fibrinogen increased thrombus formation to 20 324 and 11 367 a.u. before CPB and after CPB, respectively (P<0.001), thereby restoring post-CPB thrombus area to levels comparable with or higher than pre-CPB baseline.

Conclusions: Single valve surgery using moderately hypothermic CPB induces partial platelet dysfunction. Thrombus formation was restored in an experimental study design by ex vivo supplementation of fibrinogen.

Citing Articles

Crosstalk between GLTSCR1-deficient endothelial cells and tumour cells promotes colorectal cancer development by activating the Notch pathway.

Liu L, Han F, Deng M, Han Q, Lai M, Zhang H Cell Death Differ. 2025; .

PMID: 39870803 DOI: 10.1038/s41418-025-01450-6.

References

Ranucci M, Baryshnikova E, Crapelli G, Rahe-Meyer N, Menicanti L, Frigiola A . Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. J Am Heart Assoc. 2015; 4(6):e002066. PMC: 4599543. DOI: 10.1161/JAHA.115.002066. View

Ranucci M, Baryshnikova E, Ranucci M, Silvetti S . Fibrinogen levels compensation of thrombocytopenia-induced bleeding following cardiac surgery. Int J Cardiol. 2017; 249:96-100. DOI: 10.1016/j.ijcard.2017.09.157. View

Cattaneo M, Cerletti C, Harrison P, Hayward C, Kenny D, Nugent D . Recommendations for the Standardization of Light Transmission Aggregometry: A Consensus of the Working Party from the Platelet Physiology Subcommittee of SSC/ISTH. J Thromb Haemost. 2013; . DOI: 10.1111/jth.12231. View

Nammas W, Dalen M, Rosato S, Gherli R, Reichart D, Gatti G . Impact of preoperative thrombocytopenia on the outcome after coronary artery bypass grafting. Platelets. 2018; 30(4):480-486. DOI: 10.1080/09537104.2018.1466389. View

Schenk B, Lindner A, Treichl B, Bachler M, Hermann M, Larsen O . Fibrinogen supplementation ex vivo increasesclot firmness comparable to platelet transfusion in thrombocytopenia. Br J Anaesth. 2016; 117(5):576-582. DOI: 10.1093/bja/aew315. View

Orlov D, McCluskey S, Selby R, Yip P, Pendergrast J, Karkouti K . Platelet dysfunction as measured by a point-of-care monitor is an independent predictor of high blood loss in cardiac surgery. Anesth Analg. 2014; 118(2):257-263. DOI: 10.1213/ANE.0000000000000054. View

Straub A, Krajewski S, Hohmann J, Westein E, Jia F, Bassler N . Evidence of platelet activation at medically used hypothermia and mechanistic data indicating ADP as a key mediator and therapeutic target. Arterioscler Thromb Vasc Biol. 2011; 31(7):1607-16. DOI: 10.1161/ATVBAHA.111.226373. View

Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T . Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012; 9(7):676-82. PMC: 3855844. DOI: 10.1038/nmeth.2019. View

Gielen C, Brand A, Heerde W, Stijnen T, Klautz R, Eikenboom J . Hemostatic alterations during coronary artery bypass grafting. Thromb Res. 2016; 140:140-146. DOI: 10.1016/j.thromres.2015.12.018. View

10.

Merten M, Thiagarajan P . P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation. 2000; 102(16):1931-6. DOI: 10.1161/01.cir.102.16.1931. View

11.

Holm M, Biancari F, Khodabandeh S, Gherli R, Airaksinen J, Mariscalco G . Bleeding in Patients Treated With Ticagrelor or Clopidogrel Before Coronary Artery Bypass Grafting. Ann Thorac Surg. 2019; 107(6):1690-1698. DOI: 10.1016/j.athoracsur.2019.01.086. View

12.

Fries D, Krismer A, Klingler A, Streif W, Klima G, Wenzel V . Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. Br J Anaesth. 2005; 95(2):172-7. DOI: 10.1093/bja/aei160. View

13.

Croteau S, Frelinger 3rd A, Gerrits A, Michelson A . Decreased platelet surface phosphatidylserine predicts increased bleeding in patients with severe factor VIII deficiency. J Thromb Haemost. 2020; 19(4):976-982. DOI: 10.1111/jth.15223. View

14.

Biancari F, Mariscalco G, Gherli R, Reichart D, Onorati F, Faggian G . Variation in preoperative antithrombotic strategy, severe bleeding, and use of blood products in coronary artery bypass grafting: results from the multicentre E-CABG registry. Eur Heart J Qual Care Clin Outcomes. 2018; 4(4):246-257. DOI: 10.1093/ehjqcco/qcy027. View

15.

Barnthaler T, Mahla E, Toth G, Schuligoi R, Pruller F, Buschmann E . Supplemental Fibrinogen Restores Platelet Inhibitor-Induced Reduction in Thrombus Formation without Altering Platelet Function: An In Vitro Study. Thromb Haemost. 2020; 120(11):1548-1556. DOI: 10.1055/s-0040-1715445. View

16.

Ranucci M, Pistuddi V, Di Dedda U, Menicanti L, De Vincentiis C, Baryshnikova E . Platelet function after cardiac surgery and its association with severe postoperative bleeding: the PLATFORM study. Platelets. 2018; 30(7):908-914. DOI: 10.1080/09537104.2018.1535706. View

17.

Aubron C, Flint A, Bailey M, Pilcher D, Cheng A, Hegarty C . Is platelet transfusion associated with hospital-acquired infections in critically ill patients?. Crit Care. 2017; 21(1):2. PMC: 5217409. DOI: 10.1186/s13054-016-1593-x. View

18.

Levy J, Rossaint R, Zacharowski K, Spahn D . What is the evidence for platelet transfusion in perioperative settings?. Vox Sang. 2017; 112(8):704-712. DOI: 10.1111/vox.12576. View

19.

Ogawa S, Ohnishi T, Hosokawa K, Szlam F, Chen E, Tanaka K . Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions. Br J Anaesth. 2013; 111(6):1013-23. DOI: 10.1093/bja/aet229. View

20.

Levy J, Welsby I, Goodnough L . Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion. 2013; 54(5):1389-405. DOI: 10.1111/trf.12431. View